JULIE GILLIAM: Open Payments
NPI 1780119875 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,108 in 94 payments from 35 companies in 2025. Trend: 2023 $266 · 2024 $215 · 2025 $2,108
Food & beverage: $2,009Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $376 |
| Incyte Corporation | 8 | $169 |
| Daiichi Sankyo Inc. | 6 | $143 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| Celgene Corporation | 4 | $108 |
| SEAGEN INC. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| Genentech USA, Inc. | 4 | $79 |
| PFIZER INC. | 3 | $72 |
Products named: KISQALI, SCEMBLIX, JAKAFI, LIBTAYO, REBLOZYL, Enhertu, PADCEV, VENCLEXTA.
Industry payments across TN — which companies pay providers there.
